Floatz logo

RED BLOOD CELLS

Thalassemia Major

Cerus CorporationCell therapyPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

32 Active assets in the Thalassemia Major cohort.

Asset / SponsorPhaseRating
Deferasirox
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
DESFERRIOXAMINE B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
TACROLIMUS
M.D. Anderson Cancer Center
Phase 4BBB

View all 50 →

Same molecule, other indications

RED BLOOD CELLS is also rated in:

relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
46 / 100
View asset →
bronchopulmonary dysplasiaDormant
D
Indicative ·
30 / 100
View asset →
hereditary persistence of fetal hemoglobinDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →